Roberta Fantozzi

1.6k total citations
26 papers, 619 citations indexed

About

Roberta Fantozzi is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Roberta Fantozzi has authored 26 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 10 papers in Neurology and 8 papers in Oncology. Recurrent topics in Roberta Fantozzi's work include Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (7 papers). Roberta Fantozzi is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (7 papers). Roberta Fantozzi collaborates with scholars based in Italy, Serbia and Lebanon. Roberta Fantozzi's co-authors include Diego Centonze, Georgia Mandolesi, Alessandra Musella, Fabio Buttari, Antonietta Gentile, M. Spadaro, Francesca De Vito, Diego Fresegna, Silvia Bullitta and Paolo Bellantonio and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Neurochemistry.

In The Last Decade

Roberta Fantozzi

24 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Fantozzi Italy 12 347 156 155 116 106 26 619
Krystyna Mitosek‐Szewczyk Poland 13 306 0.9× 76 0.5× 138 0.9× 97 0.8× 100 0.9× 35 630
M. Gironi Italy 15 145 0.4× 84 0.5× 231 1.5× 91 0.8× 90 0.8× 26 578
Laura Bărcuţean Romania 12 110 0.3× 130 0.8× 160 1.0× 75 0.6× 133 1.3× 42 528
Li Du China 12 106 0.3× 188 1.2× 194 1.3× 145 1.3× 94 0.9× 31 595
Fonda Liu United States 5 275 0.8× 60 0.4× 121 0.8× 47 0.4× 112 1.1× 9 457
Kristin N. Varhaug Norway 9 204 0.6× 54 0.3× 243 1.6× 36 0.3× 167 1.6× 15 599
Alexandru Tatomir United States 13 68 0.2× 71 0.5× 132 0.9× 162 1.4× 38 0.4× 29 440
A. Garcı́a-Merino Spain 11 156 0.4× 38 0.2× 82 0.5× 105 0.9× 155 1.5× 18 480
Jonathan L. Carter United States 7 271 0.8× 42 0.3× 98 0.6× 95 0.8× 116 1.1× 12 468
Joan Feichter United States 8 394 1.1× 37 0.2× 140 0.9× 111 1.0× 149 1.4× 8 594

Countries citing papers authored by Roberta Fantozzi

Since Specialization
Citations

This map shows the geographic impact of Roberta Fantozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Fantozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Fantozzi more than expected).

Fields of papers citing papers by Roberta Fantozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Fantozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Fantozzi. The network helps show where Roberta Fantozzi may publish in the future.

Co-authorship network of co-authors of Roberta Fantozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Fantozzi. A scholar is included among the top collaborators of Roberta Fantozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Fantozzi. Roberta Fantozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Copetti, Massimiliano, Chiara Zanetta, Francesco Patti, et al.. (2025). The Italian Multiple Sclerosis Register Experience With Cladribine. Neurology Neuroimmunology & Neuroinflammation. 12(4). e200415–e200415.
2.
Buttari, Fabio, Ettore Dolcetti, Francesca Romana Rizzo, et al.. (2025). Cladribine tablets in the new multiple sclerosis era. Therapeutic Advances in Neurological Disorders. 18. 4243623943–4243623943. 2 indexed citations
3.
Zanghì, Aurora, Roberta Fantozzi, Matteo Foschi, et al.. (2025). Identifying Cladribine prescription pattern in MS: an Italian multicentre study. Therapeutic Advances in Neurological Disorders. 18. 4233585300–4233585300.
4.
Zanghì, Aurora, Giovanna Borriello, Simona Bonavita, et al.. (2024). Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study. Journal of Neurology. 271(7). 4495–4502. 6 indexed citations
5.
Signoriello, Elisabetta, Matteo Foschi, Roberta Lanzillo, et al.. (2024). Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine. Journal of Neurology. 271(7). 4039–4045. 1 indexed citations
6.
Gilio, Luana, et al.. (2022). Usability of an Application Device for Nabiximols Oromucosal Spray in Patients With Upper Limb Impaired Multiple Sclerosis. Neurodegenerative Disease Management. 12(4). 195–201. 1 indexed citations
7.
Bianco, Assunta, Matteo Lucchini, Rocco Totaro, et al.. (2021). Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients. Neurotherapeutics. 18(4). 2598–2607. 16 indexed citations
8.
Lucchini, Matteo, Luca Prosperini, Maria Chiara Buscarinu, et al.. (2021). Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis. Journal of Neurology. 268(6). 2238–2245. 12 indexed citations
9.
Bassi, Mario Stampanoni, Luana Gilio, Ennio Iezzi, et al.. (2021). Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis. Frontiers in Aging Neuroscience. 13. 694651–694651. 8 indexed citations
10.
11.
Cordioli, Cinzia, Graziella Callari, Roberta Fantozzi, et al.. (2021). Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management. Neurological Sciences. 42(4). 1515–1521. 2 indexed citations
12.
Bassi, Mario Stampanoni, Jelena Drulović, Tatjana Pekmezović, et al.. (2020). Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients. Therapeutic Advances in Neurological Disorders. 13. 1279192401–1279192401. 6 indexed citations
13.
Ciccocioppo, Fausta, Paola Lanuti, Laura Pierdomenico, et al.. (2019). The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis. Scientific Reports. 9(1). 8788–8788. 104 indexed citations
14.
Bassi, Mario Stampanoni, Fabio Buttari, Andrea Sancesario, et al.. (2019). Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients. Clinical Neurophysiology. 131(2). 566–573. 12 indexed citations
15.
Brogna, Barbara, et al.. (2017). Progression of tumefactive demyelinating lesion in a child demonstrated with MRI. Radiology Case Reports. 13(1). 254–260. 2 indexed citations
16.
Gentile, Antonietta, Diego Fresegna, Alessandra Musella, et al.. (2016). Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 13(1). 231–231. 35 indexed citations
17.
Gentile, Antonietta, Alessandra Musella, Silvia Bullitta, et al.. (2016). Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. Journal of Neuroinflammation. 13(1). 207–207. 124 indexed citations
18.
Lugaresi, Alessandra, Placido Bramanti, Maria Pia Amato, et al.. (2011). Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients. Journal of Translational Medicine. 9(1). 42–42. 10 indexed citations
19.
Pozzilli, Carlo, Giovanni Antonini, Francesca Bagnato, et al.. (2002). Monthly corticosteroids decrease neutralizing antibodies to IFNβ1b: a randomized trial in multiple sclerosis. Journal of Neurology. 249(1). 50–56. 63 indexed citations
20.
Spadaro, M., et al.. (1999). Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Multiple Sclerosis Journal. 5(2). 121–125. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krystyna Mitosek‐Szewczyk Breakdown of academic impact, for papers by M. Gironi Breakdown of academic impact, for papers by Laura Bărcuţean Breakdown of academic impact, for papers by Li Du Breakdown of academic impact, for papers by Fonda Liu Breakdown of academic impact, for papers by Kristin N. Varhaug Breakdown of academic impact, for papers by Alexandru Tatomir Breakdown of academic impact, for papers by A. Garcı́a-Merino Breakdown of academic impact, for papers by Jonathan L. Carter Breakdown of academic impact, for papers by Joan Feichter
Rankless by CCL
2026